As of 2025-05-28, the Gross Margin of GC Biopharma Corp (006280.KS) is 28.7%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 28.7% |
2023-12-31 | 29.8% |
2022-12-31 | 34% |
2021-12-31 | 33.9% |
2020-12-31 | 29.3% |
2019-12-31 | 27.4% |
2018-12-31 | 25.9% |
2017-12-31 | 28.5% |
2016-12-31 | 29.4% |
2015-12-31 | 32.4% |